UK puts £48m behind dementia trial platform and makes dementia a first HDRS priority

The UK government has committed £33 million to a dementia clinical trials partnership co-funded by Bristol Myers Squibb, GSK and Gates Ventures, bringing the total to £48 million. Prime Minister Andy Burnham also confirmed at the Innovation Nation Summit in Manchester on 9 October 2026 that dementia will be one of the first priorities of the new Health Data Research Service (HDRS) ¹².

What was announced

The government money flows through the Dame Barbara Windsor Dementia Goals programme to The BARBARA Alliance, a UK-wide not-for-profit partnership of government, industry, academia, charities and people with lived experience of dementia ¹. Its main programme, BARBARA, is meant to build one co-ordinated platform that links the UK's health data, research and clinical trial capabilities, so that researchers can find participants more easily ¹. The target is recruitment, which the government describes as one of the largest barriers in dementia research ¹.

HDRS is backed by up to £600 million from the government and the Wellcome Trust ¹. It will pull NHS and research data from across the UK into a single secure system for approved research, and scientists will be able to identify eligible patients and recruit them faster ¹. The government presents the two schemes as complementary: BARBARA to widen trial participation, HDRS to give researchers the evidence to design studies ¹.

Bristol Myers Squibb put the data at the centre of its interest. "By bringing together unique datasets that advance AI/ML approaches, BARBARA will help the Alzheimer’s field ask better questions," said Ken Rhodes, its vice president of neuroscience research ¹. Niranjan Bose of Gates Ventures called recruitment "one of the biggest bottlenecks" in developing treatments for Alzheimer's and other dementias ¹.

What it means for the market

For drug developers, the offer is a national route to trial participants and linked NHS data in a disease area where, the government says, too few people take part in research ¹. Alzheimer's Research UK, whose chief executive chairs the Dementia Goals programme, said more than 90% of people it surveyed wanted to take part in research ¹. For NHS organisations and data suppliers, dementia now sits near the front of the queue for HDRS, a flagship commitment of the 10 Year Health Plan and the Life Sciences Sector Plan ¹.

The scale of the problem frames the spending. Nearly one million people in the UK live with dementia, and the condition is estimated to cost the UK more than £42 billion a year, of which £7 billion falls on the NHS and most of the rest on social care and unpaid family care ¹.

The package follows UKRI's £80 million Dementia Challenge, launched the previous week, which will test nine technologies in the NHS, including faster MRI brain scans and remote cognitive assessments ¹. That programme aims for 92% of people to be diagnosed within 18 weeks of referral, against around 60% today ¹. In the same speech, Burnham said the Regulatory Innovation Office would gain "sandboxing powers" to suspend rules temporarily so that innovators can test ideas ².

Caveats

The announcement does not say how much each company is contributing, when the BARBARA platform will be operational, or which datasets HDRS will open first for dementia research ¹. The government also linked the funding to its plans for a National Care Service, whose timing depends on a review by Baroness Casey, who has been asked to recommend how and when to build it ¹.